FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149162265> ?p ?o ?g. }

• W2149162265 endingPage "37543" @default.
• W2149162265 startingPage "37526" @default.
• W2149162265 abstract "// So-Yeon Park 1 , Min-Jin Kim 1 , Sang-A Park 1 , Jung-Shin Kim 1 , Kyung-Nan Min 2 , Dae-Kee Kim 1 , Woosung Lim 3 , Jeong-Seok Nam 4,5 and Yhun Yhong Sheen 1 1 College of Pharmacy, Ewha Womans University, Seoul, South Korea 2 Pharmaceutical Examination Division, Korean Intellectual Property Office, Daejeon, South Korea 3 Department of Surgery, School of Medicine, Ewha Womans University, Mokdong Hospital, Seoul, South Korea 4 Laboratory of Tumor Suppressor, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, South Korea 5 Department of Molecular Medicine, School of Medicine, Gachon University, Incheon, South Korea Correspondence to: Yhun Yhong Sheen, email: // Jeong-Seok Nam, email: // Keywords : paclitaxel, metastasis, Snail, epithelial-to-mesenchymal transition (EMT), transforming growth factor-β (TGF-β) Received : July 31, 2015 Accepted : September 24, 2015 Published : October 09, 2015 Abstract Distant relapse after chemotherapy is an important clinical issue for treating breast cancer patients and results from the development of cancer stem-like cells (CSCs) during chemotherapy. Here we report that blocking epithelial-to-mesenchymal transition (EMT) suppresses paclitaxel-induced CSCs properties by using a MDA-MB-231-xenografted mice model ( in vivo ), and breast cancer cell lines ( in vitro ). Paclitaxel, one of the cytotoxic taxane-drugs such as docetaxel, increases mesenchymal markers (Vimentin and Fibronectin) and decreases an epithelial marker (Zo-1). Blocking TGF-β signaling with the TGF-β type I receptor kinase (ALK5) inhibitor, EW-7197, suppresses paclitaxel-induced EMT and CSC properties such as mammosphere-forming efficiency (MSFE), aldehyde dehydrogenase (ALDH) activity, CD44 + /CD24 - ratio, and pluripotency regulators (Oct4, Nanog, Klf4, Myc, and Sox2). The combinatorial treatment of EW-7197 improves the therapeutic effect of paclitaxel by decreasing the lung metastasis and increasing the survival time in vivo . We confirmed that Snail is increased by paclitaxel-induced intracellular reactive oxygen species (ROS) and EW-7197 suppresses the paclitaxel-induced Snail and EMT by attenuating paclitaxel-induced intracellular ROS. Knock-down of SNAI1 suppresses paclitaxel-induced EMT and CSC properties. These data together suggest that blocking the Snail-induced EMT with the ALK5 inhibitor attenuates metastasis after paclitaxel-therapy and that this combinatorial approach could prove useful in treating breast cancer." @default.
• W2149162265 created "2016-06-24" @default.
• W2149162265 creator A5000413124 @default.
• W2149162265 creator A5049568847 @default.
• W2149162265 creator A5063050737 @default.
• W2149162265 creator A5068659025 @default.
• W2149162265 creator A5069411286 @default.
• W2149162265 creator A5071676695 @default.
• W2149162265 creator A5076419129 @default.
• W2149162265 creator A5081798094 @default.
• W2149162265 creator A5085614043 @default.
• W2149162265 date "2015-10-09" @default.
• W2149162265 modified "2023-10-09" @default.
• W2149162265 title "Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells" @default.
• W2149162265 cites W1757407923 @default.
• W2149162265 cites W1861891407 @default.
• W2149162265 cites W1963965802 @default.
• W2149162265 cites W1964081206 @default.
• W2149162265 cites W1964405387 @default.
• W2149162265 cites W1965568527 @default.
• W2149162265 cites W1965822047 @default.
• W2149162265 cites W1971427890 @default.
• W2149162265 cites W1975011407 @default.
• W2149162265 cites W1979067350 @default.
• W2149162265 cites W1985339653 @default.
• W2149162265 cites W1988418033 @default.
• W2149162265 cites W1993253909 @default.
• W2149162265 cites W1994930469 @default.
• W2149162265 cites W1998196049 @default.
• W2149162265 cites W1999132074 @default.
• W2149162265 cites W2008202172 @default.
• W2149162265 cites W2009410973 @default.
• W2149162265 cites W2014691022 @default.
• W2149162265 cites W2028593825 @default.
• W2149162265 cites W2034729689 @default.
• W2149162265 cites W2042699075 @default.
• W2149162265 cites W2050562341 @default.
• W2149162265 cites W2058182256 @default.
• W2149162265 cites W2062809449 @default.
• W2149162265 cites W2063011414 @default.
• W2149162265 cites W2065629669 @default.
• W2149162265 cites W2066122607 @default.
• W2149162265 cites W2067067209 @default.
• W2149162265 cites W2073759231 @default.
• W2149162265 cites W2080119127 @default.
• W2149162265 cites W2082726109 @default.
• W2149162265 cites W2086338128 @default.
• W2149162265 cites W2087597759 @default.
• W2149162265 cites W2089704952 @default.
• W2149162265 cites W2090658591 @default.
• W2149162265 cites W2091729045 @default.
• W2149162265 cites W2092249151 @default.
• W2149162265 cites W2100999453 @default.
• W2149162265 cites W2101466169 @default.
• W2149162265 cites W2109637975 @default.
• W2149162265 cites W2112451226 @default.
• W2149162265 cites W2113638068 @default.
• W2149162265 cites W2114639059 @default.
• W2149162265 cites W2127813355 @default.
• W2149162265 cites W2135570483 @default.
• W2149162265 cites W2137005750 @default.
• W2149162265 cites W2139151018 @default.
• W2149162265 cites W2142641037 @default.
• W2149162265 cites W2143719348 @default.
• W2149162265 cites W2145063352 @default.
• W2149162265 cites W2148311640 @default.
• W2149162265 cites W2149914697 @default.
• W2149162265 cites W2156668607 @default.
• W2149162265 cites W2158501247 @default.
• W2149162265 cites W2159640574 @default.
• W2149162265 cites W2160888498 @default.
• W2149162265 cites W2166342810 @default.
• W2149162265 cites W2170552969 @default.
• W2149162265 cites W2188245412 @default.
• W2149162265 doi "https://doi.org/10.18632/oncotarget.6063" @default.
• W2149162265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4741946" @default.
• W2149162265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26462028" @default.
• W2149162265 hasPublicationYear "2015" @default.
• W2149162265 type Work @default.
• W2149162265 sameAs 2149162265 @default.
• W2149162265 citedByCount "58" @default.
• W2149162265 countsByYear W21491622652016 @default.
• W2149162265 countsByYear W21491622652017 @default.
• W2149162265 countsByYear W21491622652018 @default.
• W2149162265 countsByYear W21491622652019 @default.
• W2149162265 countsByYear W21491622652020 @default.
• W2149162265 countsByYear W21491622652021 @default.
• W2149162265 countsByYear W21491622652022 @default.
• W2149162265 countsByYear W21491622652023 @default.
• W2149162265 crossrefType "journal-article" @default.
• W2149162265 hasAuthorship W2149162265A5000413124 @default.
• W2149162265 hasAuthorship W2149162265A5049568847 @default.
• W2149162265 hasAuthorship W2149162265A5063050737 @default.
• W2149162265 hasAuthorship W2149162265A5068659025 @default.
• W2149162265 hasAuthorship W2149162265A5069411286 @default.
• W2149162265 hasAuthorship W2149162265A5071676695 @default.
• W2149162265 hasAuthorship W2149162265A5076419129 @default.
• W2149162265 hasAuthorship W2149162265A5081798094 @default.

• next